Form 4: Corcept Therapeutics Director Exercises Options and Sells Shares

Director Daniel N. Swisher Jr. exercised stock options and sold shares of Corcept Therapeutics on July 1, 2024, according to a Form 4 filing with the SEC.

Summary

• On July 1, 2024, Daniel N. Swisher Jr., a director of Corcept Therapeutics, exercised stock options to acquire 2,200 shares of common stock at a price of $5.86 per share.
• Simultaneously, Swisher sold 2,200 shares of common stock at a price of $32.81 per share.
• Following these transactions, Swisher directly owns 0 shares of Corcept Therapeutics.
• The sale was executed under a pre-arranged 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports the execution of a pre-planned transaction. The director exercised options and sold shares, which is a common practice.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders (officers, directors, or those holding more than 10% of the company's shares) buy or sell the company's securities. These filings provide transparency into insider transactions and are closely watched by investors for signals about a company's prospects.

Stakeholder Impact

• The transaction could have a minor impact on shareholders as insider transactions are often scrutinized for insights into the company's performance and future prospects.

Key Dates